Immupharma (IMM)

 

IMM Share PerformanceMore

52 week high70.32 17/02/17
52 week low31.44 09/11/16
52 week change 19.00 (50.00%)
4 week volume4,174,137 27/06/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Grant of Options

RNS Number: 8456K Immupharma PLC 12 July 2017 12 July 2017 Grant of Options ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, announces the approval of the grant of options over 1,40 0,000 ordinary shares of 10p each ("Ordinary Shares") to certain of its non-executive Directors repr...

Result of AGM

RNS Number: 7583J Immupharma PLC 30 June 2017 FOR IMMEDIATE RELEASE 30 JUNE 2017 2017 ANNUAL GENERAL MEETING - ALL RESOLUTIONS PASSED ImmuPharma PLC (LSE:IMM) , ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all res...

Broker Forecast - Northland Capital issues a broker note on ImmuPharma PLC

Northland Capital today reaffirms its buy investment rating on ImmuPharma PLC (LON:IMM) and raised its price targe...

Update on LupuzorT Pivotal Phase III Study

RNS Number: 5921J Immupharma PLC 30 June 2017 30 JUNE 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") Update on Lupuzor Pivotal Phase III Study Annual General Meeting and Investor Presentation: Today starting at 10.30am ImmuPharma PLC (LSE:IMM) , the specialist drug discovery and development company, is pleased to provide an update...

Annual Report & Notice of AGM

RNS Number: 3430H Immupharma PLC 07 June 2017 7 June 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") ANNUAL REPORT AND ACCOUNTS POSTED TO SHAREHOLDERS NOTICE OF ANNUAL GENERAL MEETING ON 30 JUNE 2017 @ 10.30 AM INVESTOR PRESENTATION TO FOLLOW AT 11.30 AM VENUE: SKY LIGHT CITY...

ImmuPharma losses widen

ImmuPharma's overall losses rose to 5.3m in the year to the end of December - up from 3.9m in 2015. The group said this w...

Final Results

RNS Number: 7561G Immupharma PLC 01 June 2017 1 JUNE 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") FINAL RESULTS ANNOUNCEMENT for the twelve months ended 31 December 2016 ImmuPharma PLC (LSE:IMM) , ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, is pleased to announce it...

Notification of Full Year Results

RNS Number: 7012F Immupharma PLC 22 May 2017 22 MAY 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") NOTIFICATION OF FULL YEAR RESULTS Date: 1 June 2017 ImmuPharma PLC (LSE:IMM) , the specialist drug discovery and development company, confirms that it will be announcing its full year results for the year ended 31 Decembe...

Fundamental DataMore

EPS-4.54
Dividend yield0 %

Latest discussion posts More

  • Re: 9.5% rise...

    Topped @ 49.25p ..10.06
    6-Jun-2017
    Ripley94
  • Re: 9.5% rise...

    sliced @ 8.45am @ 58.2p
    18-Apr-2017
    Ripley94
  • Re: 9.5% rise...

    Topped up (Thursday ) ( GTC Limit 49.75p ) on since Monday at least.
    6-Apr-2017
    Ripley94

Users' HoldingsMore

Users who hold Immupharma also hold..
LLOYDS GRP.29%
BP19%
NATIONAL GRID15%
SIRIUS MINERALS12%
ROYAL BANK SCOT12%

Codes & Symbols

ISINGB0033711010
SymbolsIMM, LSE:IMM, IMM.L, IMM:LN, LON:IMM, XLON:IMM